Back to Search
RONALD MITSUYASU, MD
MD
Hematology & Oncology Physician
NPI: 1376562215Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
G44685(CA)
Research & Publications (20)
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.
PMID 19219022·Nat Med·2009
3-trial
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
PMID 17389292·Arch Intern Med·2007
2-rct
Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients.
PMID 12001032·J Infect Dis·2002
6-review
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
PMID 10910888·Blood·2000
3-trial
Update on the pathogenesis and treatment of Kaposi sarcoma.
PMID 10750730·Curr Opin Oncol·2000
6-review
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
PMID 19194270·AIDS·2009
2-rct
Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes.
PMID 18981163·J Immunol·2008
8-other
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
PMID 18279104·J Interferon Cytokine Res·2008
3-trial
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
PMID 17109338·J Infect Dis·2006
3-trial
Quality of life in a clinical trial of highly active antiretroviral therapy alone or with intravenous or subcutaneous interleukin-2 administration.
PMID 16280697·J Acquir Immune Defic Syndr·2005
3-trial
Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individuals.
PMID 16260902·AIDS·2005
8-other
Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.
PMID 15018734·Hum Gene Ther·2004
3-trial
Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS.
PMID 15017082·Methods Mol Biol·2004
3-trial
Anemia in HIV infection: clinical impact and evidence-based management strategies.
PMID 15156485·Clin Infect Dis·2004
8-other
A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cells.
PMID 12706405·Clin Immunol·2003
3-trial
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.
PMID 12552459·J Infect Dis·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 MEDICAL PLAZA, #365,420,120,530
LOS ANGELES, CA 90095 - Phone
- (310) 794-9718
Quick Facts
- NPI
- 1376562215
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile